The GG 258 blue pill is a prescription medication containing Alprazolam 1 mg. Manufactured by Sandoz Pharmaceuticals, it is a generic equivalent of the brand-name medication Xanax.
Alprazolam belongs to the benzodiazepine class of drugs. In the United States, it is categorized as a Schedule IV controlled substance due to its potential for misuse, physical dependence, and addiction. On the street, this tablet is often colloquially referred to as a “blue football” because of its distinctive shape and color.
Physical Identification
Characteristic Details
- Active Ingredient Alprazolam (1 mg)
- Imprint “GG 258” on one side, plain on the other
- Color Light Blue
- Shape Oval / Elliptical (“Football”)
- Score Line Unscored
- Manufacturer Sandoz Pharmaceuticals
- Counterfeit Warning: Counterfeit tablets containing toxic substances (such as illicit fentanyl) are frequently pressed to mimic legitimate GG 258 pills. Never ingest a pill obtained outside of a licensed, legitimate pharmacy.
Mechanism of Action
Alprazolam acts as a central nervous system (CNS) depressant primarily by enhancing the activity of the brain’s principal inhibitory neurotransmitter, gamma-aminobutyric acid (GABA).
- GABA-A Receptor Binding: Alprazolam binds to a specific allosteric site on the GABA-A receptor complex in the central nervous system.
- Increased GABA Affinity: This binding increases the receptor’s affinity for GABA, causing an increased influx of chloride ions into postsynaptic neurons.
- Neuronal Hyperpolarization: The increased negative charge inside the neuron hyperpolarizes the cell membrane, reducing its excitability and suppressing overactive neural signals.
This produces rapid anxiolytic (anti-anxiety), sedative, muscle-relaxant, and anticonvulsant effects.
Indications & Dosage
Alprazolam is FDA-approved for the acute treatment of Generalized Anxiety Disorder (GAD) and Panic Disorder (with or without agoraphobia) in adults.
Standard Adult Dosing (Immediate-Release)
- Generalized Anxiety Disorder (GAD):
- Starting Dose: Typically 0.25 mg to 0.5 mg taken orally 3 times daily.
- Titration: The dose may be increased at intervals of 3 to 4 days.
- Maximum Dosage: 4 mg per day (administered in divided doses).
- Panic Disorder:
- Starting Dose: Typically 0.5 mg taken orally 3 times daily.
- Maintenance: Doses are titrated upward as needed; mean effective doses often fall between 3 mg and 6 mg per day in divided doses, though maximum limits can reach 10 mg per day in severe, specialized cases.
Dosage Adjustments
- Geriatric Patients & Debilitated Adults: Recommended starting dose is 0.25 mg 2 to 3 times daily to prevent severe sedation or motor impairment.
- Hepatic Impairment: Dosing should start at 0.25 mg 2 to 3 times daily due to reduced drug clearance.
Side Effects
Common Side Effects
Side effects usually peak when initiating treatment or increasing the dosage and often diminish over time:
- Drowsiness, excessive sedation, and somnolence
- Dizziness and lightheadedness
- Impaired coordination, imbalance, or unsteadiness (ataxia)
- Cognitive slowing, memory loss, or poor concentration
- Dry mouth and slurred speech
- Fatigue and muscle weakness
Serious Side Effects
Contact emergency services immediately if you experience:
- Severe Respiratory Depression: Dangerously slow, shallow, or labored breathing.
- Paradoxical Reactions: Heightened excitement, agitation, anger, rage, or hallucinations.
- Depression & Suicidal Ideation: Emergence of severe mood drops or thoughts of self-harm.
- Severe Hypersensitivity: Anaphylaxis, angioedema (swelling of face, tongue, or throat), or difficulty swallowing.
Boxed Warnings & Key Precautions
FDA Black Box Warnings
- Risks from Concomitant Use with Opioids: Combining benzodiazepines with opioids or alcohol can lead to profound sedation, severe respiratory depression, coma, and death.
- Abuse, Misuse, and Addiction: Use of alprazolam exposes users to risks of addiction, misuse, and overdose.
- Dependence and Withdrawal: Prolonged use leads to physical dependence. Abruptly stopping or rapidly tapering alprazolam can trigger life-threatening withdrawal symptoms, including status epilepticus (severe seizures), delirium, and psychosis.
Contraindications
Do not use the GG 258 tablet if you have:
- Known hypersensitivity to alprazolam or other benzodiazepines.
- Acute narrow-angle glaucoma.
- Co-administration with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole), which severely impair alprazolam metabolism.
Pregnancy & Lactation
- Pregnancy: Alprazolam passes through the placenta and can cause fetal harm, neonatal hypotonia (“floppy infant syndrome”), hypothermia, and neonatal withdrawal syndrome.
- Lactation: Excreted in breast milk; may cause severe drowsiness and weight loss in nursing infants.
Major Drug Interactions
Class / Agent Interaction Effect Precaution
- Opioids & Alcohol Additive CNS depression, respiratory arrest, and overdose. Avoid concurrent use unless strictly supervised by a physician.
- CYP3A4 Inhibitors (e.g., ketoconazole, clarithromycin) Blocks alprazolam metabolism, drastically raising blood concentration. Strictly contraindicated.
- Grapefruit Juice Inhibits intestinal CYP3A4, increasing drug absorption and risk of side effects. Avoid consuming grapefruit products while taking alprazolam.
- Central Depressants / Antipsychotics / Muscle Relaxants Enhanced sedative, hypotensive, and motor-impairing effects. Dosage reduction of one or both agents may be required.